Publications on Pao Pereira

Interested in a specific ingredient perfected by Dr. Beljanski? For your convenience we have selected on one page all the scientific publications published by Dr. Beljanski on this specific ingredient, as well as the research papers resulting from the Beljanski Foundation’s partnerships. The goal of the Foundation is to share this knowledge and increase awareness  about  scientific research conducted on natural compounds. If you care about providing scientifically researched alternatives to chemical drugs, please support the Beljanski Foundation’s research program.

Mirko Beljanski's publications

As he was developing his extracts Dr. Mirko Beljanski referred to Pao Pereira as PB100.

104. M. BELJANSKI, M.S. BELJANSKI, ”Three Alkaloids as Selective Destroyers of Cancer Cells in Mice. Synergy with Classic Anticancer Drugs“. Oncology, 43, 1986, pp. 198-203.

108. M. BELJANSKI, L. LE GOFF, M.S. BELJANSKI, ”Régulation des gènes, cancer et prévention“. Médecines nouvelles, 15, 1986, pp. 57-86.

116. M. BELJANSKI, “Cancer Therapy: A New Approach“. Deutsche Zeitschrift für Onkologie 5, 22, 1990, pp. 145-152.

117. M. BELJANSKI, “Cancer et Sida. Nouvelles approches thérapeutiques”. 5èmes Entretiens Internationaux de Monaco, 21-24 novembre 1990 (ed. du Rocher), pp. 25-37.

122. M. BELJANSKI, ”A New Approach to Cancer Therapy“. Proceedings of the international seminar: Traditional Medicine: a Challenge of the 21st Century, 7-9 Nov. 1992, Calcutta (ed. in chief Biswapati Mukherjee).

123. M. BELJANSKI, S. CROCHET, M.S. BELJANSKI, “PB100: A Potent and Selective Inhibitor of Human BCNU Resistant Glioblastoma Cell Multiplication“. Anticancer Research, vol.13, n°6A, Nov. Dec. 1993, pp. 2301-2308.

125. M. BELJANSKI, S. CROCHET, “The selective anticancer agent PB-100 inhibits interleukin-6 induced enhancement of glioblastoma cell proliferation in vitro“. International Journal of Oncology, 5:873-879, 1994.

126. M. BELJANSKI, S. CROCHET, ”Selective inhibitor (PB-100) of human glioblastoma cell multiplication“. Journal of Neuro-Oncology, Vol. 21, N°1, p. 62, 1994.

128. M. BELJANSKI, S. CROCHET, “The anticancer agent PB-100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes“. International Journal of Oncology 7:81-85, 1995.

129. M. BELJANSKI, “Novel selective nontoxic anticancer and antiviral agents“. International Journal of Oncology Vol. 7. supplement, p983, October 1995.

130. M. BELJANSKI, S. CROCHET, “The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts“. International Journal of Oncology 8:1143-1148, 1996.

131. M. BELJANSKI, S. CROCHET, “Mitogenic Effect of Several Interleukins, Neuromediators and Hormones on Human Glioblastoma Cells, and its Inhibition by the Selective Anticancer Agent PB-100“. Deutsche Zeitschrift für Onkologie, 28, 1, 1996, pp. 14-22.

133. M. BELJANSKI (posthume), “The anticancer Agent PB-100, Selectively Active on Malignant Cells, Inhibits Multiplication of Sixteen Malignant Cell Lines, even Multidrug Resistant“. Genetics and Molecular Biology 2000, vol 23 nº1, pp. 29.